Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 48,251Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Movantik

02 4Movantik/Moventig

03 7Moventig

PharmaCompass

01

Brand Name : Moventig

Naloxegol

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 22

2019 Revenue in Millions : 19

Growth (%) : 15

blank

02

Brand Name : Moventig

Naloxegol

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 24

2020 Revenue in Millions : 22

Growth (%) : 22

blank

03

Brand Name : Moventig

Naloxegol

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2022 Revenue in Millions : 23

2021 Revenue in Millions : 24

Growth (%) : -1

blank

04

Brand Name : Moventig

Naloxegol

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 12

2022 Revenue in Millions : 23

Growth (%) : -42

blank

05

Brand Name : Movantik/Moventig

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik/Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2015 Revenue in Millions : 0

2014 Revenue in Millions : 29

Growth (%) : New Launch

blank

06

Brand Name : Movantik/Moventig

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik/Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 122

2016 Revenue in Millions : 91

Growth (%) : 34

blank

07

Brand Name : Movantik/Moventig

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik/Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 109

2017 Revenue in Millions : 122

Growth (%) : -11%

blank

08

Brand Name : Movantik/Moventig

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik/Moventig

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 91

2015 Revenue in Millions : 29

Growth (%) : 214

blank

09

Brand Name : Movantik

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Opioid-induced Constipation

Currency : USD

2017 Revenue in Millions : 34

2016 Revenue in Millions : 45

Growth (%) : -25

blank

10

Brand Name : Movantik

Naloxegol Oxalate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Movantik

arrow
Pharmtech & Ingredients
Not Confirmed

Naloxegol Oxalate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 38

2017 Revenue in Millions : 31

Growth (%) : 20%

blank